 Shares of Regeneron Pharmaceuticals Inc NASDAQ: REGN have already gained about 25 since early September but a JPMorgan analyst is convinced the stock will continue to move up in the coming months. Regeneron shares could climb further to 850 Chris Schott recommends that investors buy Regeneron shares as they have upside to 850. 